Randomized Trial of Prolonged Use of Negative Pressure Wound Therapy in Patients Undergoing Surgical Procedures for the Management of Gastrointestinal Malignancies
Summary
This randomized trial will use a Negative Pressure Wound Therapy device or standard wound closure, in participants with gastrointestinal neoplasms, to measure the rate of surgical site infections
Objective
This study proposes to estimate the effectiveness of prolonged use (7 days) of NPWT in an oncologic setting. We plan to address the following aims: 1) To estimate the effectiveness rate of the NPWT dressing in decreasing wound infection for oncologic gastrointestinal surgical procedures; 2) To evaluate if usage of NPWT is associated with earlier return to intended oncologic therapy (RIOT) after surgical resections for gastrointestinal cancer; and 3) To test the difference in SSI between standard wound therapy versus NPWT in decreasing wound events after oncologic gastrointestinal procedure. We hypothesize use of the negative pressure dressing could decrease the incidence of postoperative infection complication (SSI) and possibly lead to faster initiation of antineoplastic therapy.
Scheduled surgical procedure for the management of gastrointestinal cancer
Scheduled surgical procedure planned for incision that will result in wound >5cm
Scheduled surgical procedure planned for skin wound that will be closed by primary intention with either: Staples covered by sterile Telfa® and Tegaderm® or Medipore® OR Dermal or subcuticular sutures covered by Octil®
Provision of signed and dated informed consent form
Stated willingness to comply with all study procedures and availability for the duration of the study
Scheduled surgical procedure where wound considered dirty
Scheduled surgical procedure for wound left for closure by secondary intention
Emergency surgery
Pregnancy. Pregnancy status is confirmed per protocol the day of surgery in the preoperative space by urine pregnancy test in patient younger than 65 and with intact uterus. Pregnant patient will be excluded from this study
History or current diagnosis of any medical or psychological condition that in the Investigator's opinion, might interfere with the subject's ability to participate in the study or the inability to obtain informed consent because of psychiatric or complicating medical problems
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub